SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Geriatric Psychiatry and Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Pickett, P.
Right arrow Articles by Murray, G. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pickett, P.
Right arrow Articles by Murray, G. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Psychostimulant Treatment of Geriatric Depressive Disorders Secondary to Medical Illness

Patricia Pickett

Psychiatric Consult Service, Massachusetts General Hospital, Boston, MA

Prakash Masand

Psychiatric Consult Service, Massachusetts General Hospital, Boston, MA

George B. Murray

Psychiatric Consult Service, Massachusetts General Hospital, Boston, MA

The records were reviewed for 129 medically ill geriatric inpatients treated with either dextroamphetamine or methylphenidate for secondary depression during a five year period at the Massachusetts General Hospital. Eighty-one percent of patients demonstrated at least some improvement following psychostimulant treatment. Sixty-six percent of these experienced marked to moderate amelioration of their depressive symptoms. Improvement was rapid and usually occurred within the first or second day of treatment. No significant difference in efficacy was noted between the two psychostimulants or across diagnostic categories for depression. Only 8% of patients experienced adverse reactions significant enough to warrant termination of the psychostimulant trial. No instances of anorexia due to psychostimulant treatment were observed. (J Geriatr Psychiatry Neurol 1990;3:146-151).

Journal of Geriatric Psychiatry and Neurology, Vol. 3, No. 3, 146-151 (1990)
DOI: 10.1177/089198879000300304


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Nutr Clin PractHome page
C. Jarvis
Methylphenidate for Appetite Stimulation in Older Patients
Nutr Clin Pract, April 1, 1998; 13(2): 66 - 69.
[Abstract] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. J. Knesper
The Depressions of Alzheimer's Disease: Sorting, Pharmacotherapy, and Clinical Advice
J Geriatr Psychiatry Neurol, October 1, 1995; 8(1): S40 - S51.
[Abstract] [PDF]



Advertisement